IL7 and neoplasm: Considering that the difference in antitumor efficacy with and without IL-7 became apparent after a period of tumor suppression of one or two weeks, other immune phenotype changes, such as TCR repertoire, may have had a lasting effect on the degree of antitumor efficacy in the tumor microenvironment.